PIERRE FABRE INVEST

Pierre Fabre Invest operates as an investment firm.

#SimilarOrganizations #Financial #More

PIERRE FABRE INVEST

Social Links:

Status:
Active


Similar Organizations

base-investments-logo

Base Investments

Base Investments operates as an investment firm.

not_available_image

BPC Investments

BPC Investments operates as an investment firm.

not_available_image

Fadeed Investment

Fadeed Investment operates as an investment firm.

not_available_image

OMQ Investments

OMQ Investments operates as an investment firm.

not_available_image

Terrain Invest

Terrain Invest operates as an investment firm.

not_available_image

Toss Investment

Toss Investment operates as an investment firm.

not_available_image

VEST Investment

VEST Investment operates as an investment firm.

not_available_image

VJ Invest

VJ Invest operates as an investment firm.

Investments List

Date Company Article Money raised
2023-09-20 TOLREMO therapeutics Pierre Fabre Invest investment in Series A - TOLREMO therapeutics 3.41 M CHF
2022-10-10 Gennisium Pierre Fabre Invest investment in Venture Round - Gennisium N/A

More informations about "Pierre Fabre Invest"

Our Employee Shareholding, Unique in France | Pierre Fabre

The Pierre Fabre Group is majority owned by a government-recognized public-interest foundation (via decree dated April 6, 1999): the Pierre Fabre Foundation. Mr. Pierre Fabre had already …See details»

Pierre Fabre Invest acquires a majority stake in the share capital of ...

Nov 30, 2021 Castres (Tarn) and Saillans (Drôme), November 22, 2021 - Pierre Fabre Invest, a Pierre Fabre Group subsidiary dedicated to investments, has announced the acquisition of a …See details»

Pierre Fabre Invest - Investments, Portfolio & Company Exits

Oct 10, 2022 Pierre Fabre Invest has made 2 investments. Their most recent investment was on Sep 20, 2023, when TOLREMO therapeutics raised. obfuscated. obfuscated. How many …See details»

PIERRE FABRE INVEST Company Profile - Dun & Bradstreet

Pierre fabre invest. d&b business directory home / business directory / finance and insurance / funds, trusts, and other financial vehicles / other investment pools and funds / france / …See details»

Pierre Fabre Company Profile 2024: Valuation, Funding ... - PitchBook

Pierre Fabre Invest: Other Commercial Products: Castres, France: Ladrôme Laboratoire: Personal Products: Saillans, France: Pierre Fabre (Research & Development Centre in Saint Julien, …See details»

Gennisium - Crunchbase Company Profile & Funding

Oct 10, 2022 Gennisium is funded by Pierre Fabre Invest. When was the last funding round for Gennisium? Gennisium closed its last funding round on Oct 10, 2022 from a Venture - Series …See details»

Pierre Fabre is taking a minority stake, via its dedicated …

Oct 10, 2022 Pierre Fabre will help Gennisium build up its product portfolio, its organization and its market access across the world, by investing in existing operations, potential licensing agreements and expertise sharing in the field of …See details»

Pierre Fabre Invest Investments, Co-Investors & Top Startups

Pierre Fabre Invest - Free Access to Portfolio, Investments, Co-Investors, General Partners, Top Startups, Exits, IPOs, Unicorns data.See details»

Pierre Fabre is taking a minority stake in Gennisium Pharma

Pierre Fabre is taking a minority stake, via its dedicated investment subsidiary Pierre Fabre Invest, in Gennisium Pharma, an innovative company specializing in medicines for premature …See details»

Pierre Fabre is taking a minority stake, via its dedicated …

Oct 10, 2022 Pierre Fabre will help Gennisium build up its product portfolio, its organization and its market access across the world, by investing in existing operations, potential licensing agreements and ...See details»

Pierre Fabre Invest - Tech Stack, Apps, Patents & Trademarks

Pierre Fabre Invest . Connect to CRM . Save . Summary. Investments. People. Technology. Signals & News. Similar Companies. IT Spend by Aberdeen. Edit IT Spend by Aberdeen …See details»

Pierre Fabre is taking a minority stake, via its dedicated investment ...

Oct 10, 2022 Gennisium finds a strategic partner with global experience and connections in the pharmaceutical industry to accelerate its development in neonato...See details»

INTEGRATED REPORT 2020 - static.pierre-fabre.com

Overview of the value created by the Pierre Fabre Group for all of its stakeholders. The timing of the publication of this report is particularly fortuitous. Indeed, in 2019, the Pierre Fabre Group …See details»

Pierre Fabre Invest acquires a majority stake in the share capital of ...

Castres (Tarn) and Saillans (Drôme), November 22, 2021 - Pierre Fabre Invest, a Pierre Fabre Group subsidiary dedicated to investments, has announced the acquisition of a majority stake …See details»

Pierre Fabre - Funding, Financials, Valuation & Investors

Pierre Fabre is a pharmaceutical manufacturing firm that supplies skincare, haircare, personal care, and dermo cosmetic products. ... Their most recent investment was on Sep 27, 2021, …See details»

CARING FOR EACH PERSON helps us advance - Laboratoires …

Of Pierre Fabre Laboratories, all committed to making the whole world better. Pierre Fabre and you, shared stories: €2.7 billion in revenues in 2022. OUR ACTIVITY IN FIGURES: Annual …See details»

TAKING CARE, LIVING BETTER - Laboratoires Pierre Fabre

Organization 1989 Launch of the cancer drug Navelbine® from tropical periwinkle 2010 Opening of the R&D center on the Oncopole campus in Langlade (Toulouse) ... • Allowing the Pierre …See details»

Pierre Fabre - Crunchbase Company Profile & Funding

Pierre Fabre Group, also known as Laboratoires Pierre Fabre, operates as a pharmaceutical company in France and internationally. It offers pharmaceutical, dermo-cosmetic, and family …See details»

Group Governance and Board of Directors | Pierre Fabre

Investing heavily in R&D; Prioritizing long-term goals rather than short-term financial results; ... Pierre Fabre Médicament and Pierre Fabre Dermo-Cosmétique are the main subsidiaries of …See details»

linkstock.net © 2022. All rights reserved